Background:
Introduction
Si nce 2002, the American Foundation for the Blind has been focusing on the interface design of diabetesrelated self-management technology such as blood glucose meters, insulin pumps (IPs), blood pressure monitors, and insulin pens. 1 The reason for this is that, of the 17.9 million people diagnosed with diabetes (another 5.7 million are believed to be undiagnosed 2 ), 11% (2.6 million) are believed to have some level of visual impairment.
3 It should be noted that visual problems are more prevalent among type 2 diabetes patients who make up a smaller percentage of IP users. Although it is difficult to find estimates of the number of people with diabetes who are blind or visually impaired and who are candidates for insulin treatment and intensive management, there are reliable projections of IP usage among the entire diabetes population. Insulin pump usage among type 1 diabetes patients is expected to reach 476,000 users (37.8% of type 1 patients) in 2009, a significant increase from only 178,000 (17%) in 2002. This positive trend is expected to continue. 4, 5 Insulin pump usage among insulin-treated and intensively managed type 2 diabetes patients has risen from only 600 in 2002 (0.3% of insulin-treated intensively managed type 2 diabetes patients) to an estimated 17,600 (6.0%) in 2009, a rise of nearly 3000% in 7 years. This market is expected to grow rapidly in coming years. 4, 5 Simply stated, an IP is accessible to a blind or visually impaired person if it is designed so that the person can independently operate it without the need for sighted assistance. The product design criteria for IPs to be accessible to and usable by blind and visually impaired persons are of two types. First and foremost are criteria that are related to using the device nonvisually or with a visual limitation:
Spoken display data.
High-contrast, large-font display and the option for reverse contrast polarity.
Control buttons that are tactually identifiable.
An accessible operating manual (i.e., large print 6 and in an electronic format that can be read by PC screenreading or magnifying software).
Second are design criteria related to the overall convenience and ease of use.
1.

2.
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Examples of convenience and ease-of-use design criteria are as follows:
Highly portable.
Tasks must be simple, highly tactile, and not require a high level of manual dexterity. These tasks include battery replacement, reservoir filling and replacement, and infusion insertion, connection, and disconnection.
In 2004, Uslan and associates reported that most IPs on the market featured tactually identifiable control buttons.
7 In most cases, infusion set up and reservoir replacement required considerable manual dexterity but were manageable even for those without useable vision.
However, the 2004 IPs had not been designed to meet accessibility design criteria. To varying degrees, they provided some limited audio output in the form of tones and beeps, but none had spoken output of display information. This audio output was found to be of minimal use to people who are blind or visually impaired other than for providing assistance with setting a bolus injection. None of the 2004 IPs used highcontrast displays with consistently large fonts preferred by people who are visually impaired. They also did not have an option for reverse contrast polarity (white text on a black background), which is preferred by many visually impaired people. User manuals were also found to be less accessible than required. Results Table 1 shows that the average size and weight of IPs, which affect portability and ease of use, have not changed significantly. A pump with the ability to be programmed with a PC adds the potential for added accessibility as long as the software used to do this is compatible with screen-reader and magnifier software. Table 1 shows A computer-controlled Canon EOS 40D camera with an attached Canon EF 200 mm lens, reticle, and integrated light source that that works in conjunction with IMAQ Vision Builder image analysis software was used to measure contrast, resolution, and font size. Although the average number of control buttons increased by 2008, the complexity related to using the buttons did not. Raised and textured buttons aid in button identification. 
Discussion
The Insulet OmniPod has a unique design that is distinct from the other IPs. Its control interface is on a separate remote control that communicates wirelessly with the insulin-delivery unit. The delivery unit has no control buttons, and it is much smaller than the other IPs. It is a stick-on unit with an adhesive for connecting it directly on your skin. When it is primed and ready, a press of a button on the remote control causes it to automatically improved visual interface indicates that progress has been made in one IP in regard to accessibility for persons with low vision who function visually. Improvements in resolution, contrast, and color have been observed, but font sizes are no larger than the average font sizes of the other IP displays.
Overall, a slight improvement in the tactile nature of control buttons was noted, but that was not a major problem in 2004. As was the case in 2004, the criteria related to operating manuals were not met in 2008.
Regarding convenience and ease-of-use design criteria, it is easier to change the batteries on the 2008 IPs, and one IP, the OmniPod, has significantly enhanced the ease of infusion set-up.
It can therefore be concluded that there is still not an IP on the market designed with enough accessibility features for a person with significant vision loss to independently operate it without the need for sighted assistance.
To rectify this situation, IP manufacturers should consider the following design recommendations:
Include speech output for all menu navigation, programming, and warning/alarm messages. This could be designed into the pump itself or via an accessible remote control.
Incorporate high-contrast visual display technology and consistent use of large font sizes as well as a reverse contrast polarity option for all displayed information.
Produce all manuals and other documentation in accessible formats, including large print, audio, and electronic format such as text or HTML. Braille should also be available upon request.
Use a prefilled insulin cartridge instead of having users inject insulin manually.
Manufacturers might also consider providing a "try before you buy" policy so that blind and visually impaired persons can make a more informed choice of which IP is best for them. This will be especially important once manufacturers begin to design significant accessibility into their pumps.
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• insert a cannula into the skin for insulin delivery. The OmniPod's unique design approach has several effects on accessibility and usability. Because its controls are on a separate remote control unit, its insulin delivery unit is smaller and less obtrusive than the other IPs on the market, which increases usability. Its automatic infusion process removes accessibility barriers and possibilities for human error related to the connection and infusion steps required by traditional IPs. There are also no wires that can get tangled in clothes or accidentally ripped loose during physical activity.
Although the wireless communication capabilities of the Insulet OmniPod and MiniMed 515 do not currently provide accessibility solutions, they do provide possible new ways to make IPs more accessible. A remote control has more options for designing in accessibility, because it is not confined to the small footprint desired by an insulin delivery system. There would be more room for a larger, more viewable display, and there would be more room for larger, easier-to-identify, easier-to-use buttons.
The authors had previously assumed that the speech output required to make pumps fully accessible would have to be built into the pumps themselves. However, an accessible remote control might be an alternative solution. Manufacturers could focus on building speech access into the remote controls and not worry about reconfiguring the electronics of the pump itself. Because of the portability advantages, a strategy of designing accessibility into a remote control device would also be a much more practical solution than designing accessibility into the PC software that can control some pumps.
One might argue that having to carry an additional remote control device adds to the overall complexity of insulin delivery. However, the IP controls could be built into existing wireless devices that people already carry. There are currently several software programs that make cell phones and hand-held PDAs accessible to people who are blind or have low vision, and perhaps they could be configured to control IPs.
Conclusions and Recommendations
Although there have been some minor improvements, no substantial progress was made between 2004 and 2008 in the accessibility of IPs to persons who function nonvisually. None of the 2008 IPs had added the necessary speech output to convey visual display information, and this lack of speech output is still the main barrier to the accessibility and usability of IPs for people who function nonvisually. On the other hand, the Animus IR 2020's
